| Product Code: ETC7661510 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Secukinumab Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Secukinumab Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Secukinumab Market - Industry Life Cycle |
3.4 Israel Secukinumab Market - Porter's Five Forces |
3.5 Israel Secukinumab Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Secukinumab Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Israel Secukinumab Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Israel Secukinumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Israel Secukinumab Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Israel Secukinumab Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Secukinumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis and psoriatic arthritis in Israel |
4.2.2 Growing awareness about the benefits of secukinumab for treating autoimmune diseases |
4.2.3 Favorable government initiatives and policies supporting the use of biologic therapies like secukinumab |
4.3 Market Restraints |
4.3.1 High cost associated with secukinumab treatment may limit adoption rates |
4.3.2 Stringent regulatory requirements for approval and reimbursement of biologic drugs in Israel |
5 Israel Secukinumab Market Trends |
6 Israel Secukinumab Market, By Types |
6.1 Israel Secukinumab Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Secukinumab Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Secukinumab Market Revenues & Volume, By Sensoready Pen, 2021- 2031F |
6.1.4 Israel Secukinumab Market Revenues & Volume, By Prefilled Syringe, 2021- 2031F |
6.1.5 Israel Secukinumab Market Revenues & Volume, By Powder for Solution, 2021- 2031F |
6.2 Israel Secukinumab Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Israel Secukinumab Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.2.3 Israel Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Secukinumab Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Israel Secukinumab Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Israel Secukinumab Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Israel Secukinumab Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Israel Secukinumab Market Revenues & Volume, By Ankylosing Spondylitis, 2021- 2031F |
6.4.3 Israel Secukinumab Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.4.4 Israel Secukinumab Market Revenues & Volume, By Plaque Psoriasis, 2021- 2031F |
6.4.5 Israel Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Secukinumab Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Secukinumab Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Israel Secukinumab Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Israel Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Secukinumab Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Secukinumab Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Secukinumab Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Secukinumab Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Israel Secukinumab Market Import-Export Trade Statistics |
7.1 Israel Secukinumab Market Export to Major Countries |
7.2 Israel Secukinumab Market Imports from Major Countries |
8 Israel Secukinumab Market Key Performance Indicators |
8.1 Patient adherence rate to secukinumab treatment |
8.2 Number of healthcare providers trained in prescribing and administering secukinumab |
8.3 Rate of adverse reactions reported for secukinumab |
9 Israel Secukinumab Market - Opportunity Assessment |
9.1 Israel Secukinumab Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Secukinumab Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Israel Secukinumab Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Israel Secukinumab Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Israel Secukinumab Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Israel Secukinumab Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Secukinumab Market - Competitive Landscape |
10.1 Israel Secukinumab Market Revenue Share, By Companies, 2024 |
10.2 Israel Secukinumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here